Funding round brings in $6M for back pain drug developer

08/22/2013 | MedCityNews.com

Semnur Pharmaceuticals secured $6 million toward a funding round targeted at $30 million. The firm will use the proceeds to further develop its injectable drug for lower back pain. The drug is expected to enter midstage trials late next year.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA